Bright Minds Biosciences Inc.

NasdaqCM:DRUG Stock Report

Market Cap: US$283.5m

Bright Minds Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:DRUG Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Dec 24SellUS$998,561Jan PedersenIndividual25,000US$39.94
12 Nov 24SellUS$653,408Nils BottlerIndividual16,000US$40.84
08 Nov 24SellUS$287,589Ryan E. S. CheungIndividual5,000US$57.65
05 Nov 24SellUS$528,453Alex VasilkevichIndividual10,000US$52.85
05 Nov 24SellUS$271,474Nils BottlerIndividual5,400US$56.25
04 Nov 24BuyUS$4,099,998Jeremy FryzukIndividual188,940US$21.70
04 Nov 24BuyUS$3,999,983Cormorant Asset Management, LPCompany184,331US$21.70
04 Nov 24BuyUS$100,015Jeremy FryzukIndividual4,609US$21.70
30 Oct 24SellUS$166,624Nils BottlerIndividual3,600US$48.76
16 Oct 24BuyUS$3,234,387Cormorant Asset Management, LPCompany422,591US$25.22
16 Oct 24BuyUS$4,934,500Cormorant Asset Management, LPCompany875,000US$23.45
16 Oct 24SellUS$8,775,000Ian McDonaldIndividual300,000US$29.25
15 Oct 24SellUS$70,052Jeremy FryzukIndividual2,400US$29.19

Insider Trading Volume

Insider Buying: DRUG insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of DRUG?
Owner TypeNumber of SharesOwnership Percentage
Institutions291,4574.17%
VC/PE Firms890,82912.7%
Individual Insiders1,574,75922.5%
Hedge Funds1,894,33127.1%
General Public2,337,61333.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.6%.

Top Shareholders

Top 18 shareholders own 66.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
Cormorant Asset Management, LP
1,059,331US$43.0m0%2.28%
14.4%
Ian McDonald
1,004,900US$40.8m3.08%no data
6.88%
Alan Kozikowski
480,500US$19.5m0%no data
6.59%
RA Capital Management, L.P.
460,829US$18.7m0%0.22%
6.22%
Point72 Asset Management, L.P.
435,000US$17.6m0%0.04%
6.15%
Perceptive Advisors LLC
430,000US$17.4m0%0.36%
5.72%
Commodore Capital LP
400,000US$16.2m0%1.03%
2.61%
AdvisorShares Investments, LLC
182,420US$7.4m0.79%1.01%
1.43%
Logos Global Management, L.P.
100,000US$4.1m0%0.48%
0.86%
Jan Pedersen
60,000US$2.4m0%no data
0.28%
Alex Vasilkevich
19,750US$801.2k0%no data
0.072%
Nils Bottler
5,000US$202.8k25%no data
0.071%
National Bank Investments Inc.
4,959US$201.1k-0.82%no data
0.066%
Jeremy Fryzuk
4,609US$187.0k92%no data
0.049%
UBS Asset Management AG
3,407US$138.2k0%no data
0.0094%
RBC Dominion Securities Inc., Asset Management Arm
660US$26.8k29.4%no data
0.00014%
R Squared Ltd
10US$396.90%no data
0.00001%
BlackRock, Inc.
1US$28.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 16:47
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bright Minds Biosciences Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Charles DuncanCantor Fitzgerald & Co.
Sepehr ManochehryEight Capital